Effects of Ionizing Radiation on Intestinal Bile Acid Metabolism: Mechanism of the Radioprotective Effect of Glycoursodeoxycholic Acid

DAI Jun, GAO Yi, WANG Jian, ZHANG Shuyu, LIU Pengfei

Abstract

Radioactive intestinal injury is a common complication during radiotherapy of tumors. The aim of this study is to observe the effect of ionizing radiation on short-term changes in intestinal bile acids and to investigate the radioprotective effect of bile acids on intestinal cells.

Methods 

A rat model of small intestinal injury was constructed by exposing the abdomen of the rats to daily irradiation at 2 Gy for 4 d in succession. The bile acids were quantified using metabolomics analysis. IEC-6 cells, a small intestinal epithelial cell line, were divided into a dimethyl sulfoxide (DMSO) control group receiving DMSO and 0 Gy irradiation, a glycoursodeoxycholic acid (GUDCA) experimental group receiving GUDCA and 0 Gy irradiation, a DMSO irradiation group receiving DMSO and 10 Gy irradiation, and a GUDCA irradiation group receiving GUDCA and 10 Gy irradiation. Cell viability and cytotoxicity was assessed by CCK-8 assay test. The apoptosis rate of cells was determined by flow cytometry. The colony formation rate and the radiosensitivity of the cells were determined by colony formation assay on solid media. The expression levels of proteins associated with cell death were determined using Western blot.

Results 

After exposure to irradiation, the small intestine tissues of the rats showed typical radioactive intestinal injury. In addition, various bile acids showed fluctuation before and after irradiation. Among the bile acids, GUDCA increased significantly at 3 d after irradiation, but returned to the pre-irradiation level at 7 d after irradiation. Compared with the control group, after GUDCA treatment at 20 μmol/L for 24 h, the cell viability rate after irradiation was significantly higher than that of the DMSO group (P<0.05); the expression levels of the proteins, including PARP, caspase-3, RIP, and GSDMD, were significantly lower than those in the control group (P<0.05). After GUDCA treatment at 20 μmol/L for 24 h and 48 h, the cell apoptosis rate of the cells after irradiation was lower than that of the DMSO group (P<0.05). Compared with the DMSO control group, the colony formation ability of the GUDCA experimental group was stronger than that of the DMSO group after irradiation at 0, 2, 4, and 6 Gy (P<0.05). D0, or the mean lethal dose, of the GUDCA group was 6.374, while that of the DMSO group was 4.572. Compared with the DMSO control group, the D0 value of the GUDCA treatment group increased, and the sensitization enhancement ratio (SER) was 0.717.

Conclusion 

After exposing the abdomen of rats to irradiation, the intestinal bile acid metabolism of the rats will change significantly, and GUDCA can produce radioprotective effects on intestinal cells to a certain extent.

 

Keywords: Radiation enteritis, Bile acids, Glycoursodeoxycholic acid, Apoptosis, Radiation protection

 

Full Text:

PDF


References


• LI S, LI Q, REN Y, et al. HSV: the scout and assault for digestive system tumors. Front Mol Biosci, 2023, 10: 1142498. doi: 10.3389/fmolb.2023. 1142498.

• HUANG H, YAO Y, DENG X, et al. Immunotherapy for nasopharyngeal carcinoma: current status and prospects (review). Int J Oncol, 2023, 63(2): 97. doi: 10.3892/ijo.2023.5545.

• ALFOUZAN A F. Radiation therapy in head and neck cancer. Saudi Med J, 2021, 42(3): 247–254. doi: 10.15537/smj.2021.42.3.20210660.

• ANTUNAC K. Radiotherapy of prostate cancer: primary radiotherapy and radiotherapy in disease relapse. Acta Clin Croat, 2019, 58(Suppl 2): 46–59. doi: 10.20471/acc.2019.58.s2.08.

• FENG C H, MELL L K, SHARABI A B, et al. Immunotherapy with radiotherapy and chemoradiotherapy for cervical cancer. Semin Radiat Oncol, 2020, 30(4): 273–280. doi: 10.1016/j.semradonc.2020.05.003. CAO C, LUO J, GAO L, et al. Definitive radiotherapy for cervical esophageal cancer. Head Neck, 2015, 37(2): 151–155. doi: 10.1002/hed. 23572.

• NICOLAY N H, LOPEZ PEREZ R, DEBUS J, et al. Mesenchymal stem cells--a new hope for radiotherapy-induced tissue damage? Cancer Lett, 2015, 366(2): 133–140. doi: 10.1016/j.canlet.2015.06.012. CAMPRODON G, HUGUET F. Unrecognized digestive toxicities of radiation therapy. Cancer Radiother, 2021, 25(6): 723–728. doi: 10.1016/j. canrad.2021.07.007.

• WU Y, SONG Y, WANG R, et al. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer, 2023, 22(1): 96. doi: 10.1186/s12943-023-01801-2.

• WANG L, WANG A, FU Q, et al. Ferroptosis plays an important role in promoting ionizing radiation-induced intestinal injuries. Biochem Biophys Res Commun, 2022, 595: 7–13. doi: 10.1016/j.bbrc.2022.01.068.

• FAN J, LIN B, FAN M, et al. Research progress on the mechanism of radiation enteritis. Front Oncol, 2022, 12: 888962. doi: 10.3389/fonc.2022. 888962.

• VERGINADIS I I, KANADE R, BELL B, et al. A novel mouse model to study image-guided, radiation-induced intestinal injury and preclinical screening of radioprotectors. Cancer Res, 2017, 77(4): 908–917. doi: 10. 1158/0008-5472.CAN-16-2724.

• TRIPATHI A, DAVIS J D, STAREN D M, et al. CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1alpha and ubiquitin. Cytokine, 2014, 65(2): 121–125. doi: 10.1016/j.cyto.2013.12.008.

• STANGELBERGER A, SCHALLY A V, VARGA J L, et al. Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancers. Prostate, 2005, 64(3): 303–315. doi: 10. 1002/pros.20262.

• Di GREGORIO M C, CAUTELA J, GALANTINI L. Physiology and physical chemistry of bile acids. Int J Mol Sci, 2021, 22(4): 1780. doi: 10. 3390/ijms22041780.

• CAI J, RIMAL B, JIANG C, et al. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther, 2022, 237: 108238. doi: 10.1016/j.pharmthera.2022.108238.

• DING L, YANG L, WANG Z, et al. Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharm Sin B, 2015, 5(2): 135–144. doi: 10. 1016/j.apsb.2015.01.004.

• LI T, APTE U. Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv Pharmacol, 2015, 74: 263–302. doi: 10. 1016/bs.apha.2015.04.003.

• JIA W, RAJANI C, KADDURAH-DAOUK R, et al. Expert insights: the potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer's disease and hepatic encephalopathy. Med Res Rev, 2020, 40(4): 1496–1507. doi: 10.1002/med. 21653.

• WEBB G J, BROOKE R, De SILVA A N. Chronic radiation enteritis and malnutrition. J Dig Dis, 2013, 14(7): 350–357. doi: 10.1111/1751-2980. 12061.

• SOUIDI M, SCANFF P, GRISON S, et al. Effects of ionizing radiation on the activity of the major hepatic enzymes implicated in bile acid biosynthesis in the rat. C R Biol, 2007, 330(12): 861–870. doi: 10.1016/j. crvi.2007.03.012.

• SULLIVAN M F, HULSE E V, MOLE R H. The mucus-depleting action of bile in the small intestine of the irrad iated rat. Br J Exp Pathol, 1965, 46(3): 235-244.

• MULHOLLAND M W, LEVITT S H, SONG C W, et al. The role of luminal contents in radiation enteritis. Cancer, 1984, 54(11): 2396–2402. doi: 10.1002/1097-0142(19841201)54:11<2396::aid-cncr2820541115>3.0. co;2-3.

• ZHANG Y, YAN T, MO W, et al. Altered bile acid metabolism in skin tissues in response to ionizing radiation: deoxycholic acid (DCA) as a novel treatment for radiogenic skin injury. Int J Radiat Biol, 2024, 100(1): 87–98. doi: 10.1080/09553002.2023.2245461.

• BASKAR R, LEE K A, YEO R, et al. Cancer and radiation therapy: current advances and future directions. Int J Med Sci, 2012, 9(3): 193–199. doi: 10. 7150/ijms.3635.

• WANG K, TEPPER J E. Radiation therapy-associated toxicity: etiology, management, and prevention. CA Cancer J Clin, 2021, 71(5): 437–454. doi: 10.3322/caac.21689.

• LI T, CHIANG J Y. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev, 2014, 66(4): 948–983. doi: 10.1124/pr.113. 008201.


Refbacks

  • There are currently no refbacks.